Bayer A G Ord (OP:BAYZF)

49.70 -0.28 (-0.56%)

Delayed Quote Updated: 12:12 PM EDT, Oct 16, 2026 Add to My Watchlist

Price and Volume

Volume	873
Open	49.70
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	49.98
Today's Range	49.70 - 50.04
52wk Range	30.00 - 61.38
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting

October 08, 2026

From Bayer

Via Business Wire

Actress and Menopause Advocate Melissa Joan Hart Partners with Bayer to Raise Awareness about Lynkuet® (elinzanetant), a Prescription Treatment for Moderate to Severe Hot Flashes due to Menopause

October 08, 2026

From Bayer

Via Business Wire

Performance

52-Week Range 19.0% below 52-week high

49.70

30.0052W Low 61.3852W High

1 Week 0.7% below 1-week high

48.841W Low 50.041W High

Bayer A G Ord (BAYZF) traded between $30.00 and $61.38 over the past 52 weeks and last traded at $49.70, 19.0% below its 52-week high. Over the past week it ranged between $48.84 and $50.04.

Past 12 Months

+1.8%

-9.6%

-5.9%

+3.4%

+10.6%

+55.6%

1W +$0.86

1M -$5.30

3M -$3.10

6M +$1.64

YTD +$4.77

1Y +$17.76

BAYZF was +55.6% over the past year, +3.4% over six months, +10.6% year to date, +1.8% in the last week.

12 Months vs Market

BAYZF

+55.6%

DIA

+12.4%

SPY

+14.9%

QQQ

+17.5%

IWM

+11.1%

Over the past 12 months BAYZF returned +55.6% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.15× 3-mo avg

Today 873 3-mo avg 5.8K

4.4K

6.5K

5.8K

4.6K

YTD

5.2K

5.1K

BAYZF most recently traded 873 shares against a 3-month average daily volume of 5.8K.

More News

U.S. FDA Accepts Bayer’s Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes

October 08, 2026

From Bayer

Via Business Wire

Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States

October 02, 2026

From Bayer

Via Business Wire

Alka-Seltzer Plus® to Relaunch as Alka-Seltzer™ Cold in 2026, Bringing Simpler Shopping and More Value to the Cough/Cold Aisle

October 01, 2026

From Bayer

Via Business Wire

MiraSOFT™ Launch at CVS Pharmacy, Expanding the MIRA Portfolio with a Stool Softener Option

September 29, 2026

From Bayer

Via Business Wire

U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer

September 28, 2026

From Bayer

Via Business Wire

Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs

September 17, 2026

From Bayer

Via Business Wire

Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes

September 17, 2026

From Bayer

Via Business Wire

Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road

September 10, 2026

From Bayer

Via Business Wire

U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer

September 09, 2026

From Bayer

Via Business Wire

BAYER INITIATES PHASE II STUDY OF INVESTIGATIONAL GIRK4 INHIBITOR IN PATIENTS WITH ATRIAL FIBRILLATION

September 09, 2026

From Bayer

Via Business Wire

Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

August 30, 2026

From Bayer

Via Business Wire

Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026

August 20, 2026

From Bayer

Via Business Wire

One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin

July 28, 2026

From Bayer

Via Business Wire

New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters

July 23, 2026

From Bayer

Via Business Wire

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

July 17, 2026

From Bayer

Via Business Wire

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

July 14, 2026

From Bayer

Via Business Wire

The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials

July 07, 2026

From Bayer

Via Business Wire

Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart

July 02, 2026

From Bayer

Via Business Wire

Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon

July 01, 2026

From Bayer

Via Business Wire

Bayer and Iambic Collaborate to Advance Drug Discovery with AI

June 22, 2026

From Bayer

Via Business Wire

Bayer Completes Acquisition of Perfuse Therapeutics

June 17, 2026

From Bayer

Via Business Wire

Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief

June 16, 2026

From Bayer

Via Business Wire

Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions

June 15, 2026

From Bayer

Via Business Wire

Frequently Asked Questions

Is Bayer A G Ord publicly traded?

Yes, Bayer A G Ord is publicly traded.

What exchange does Bayer A G Ord trade on?

Bayer A G Ord trades on the OTC Traded

What is the ticker symbol for Bayer A G Ord?

The ticker symbol for Bayer A G Ord is BAYZF on the OTC Traded

What is the current price of Bayer A G Ord?

The current price of Bayer A G Ord is 49.70

When was Bayer A G Ord last traded?

The last trade of Bayer A G Ord was at 10/16/26 12:12 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.